US Stock MarketDetailed Quotes

AGNPF ALGERNON PHARMACEUTICALS INC

Watchlist
  • 0.067000
  • -0.022000-24.72%
15min DelayTrading Apr 25 09:30 ET
1.45MMarket Cap-328P/E (TTM)

About ALGERNON PHARMACEUTICALS INC Company

Algernon Pharmaceuticals, Inc. is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them into new human trials, developing new formulations and seeking new regulatory approvals in global markets. It specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada.

Company Profile

SymbolAGNPF
Company NameALGERNON PHARMACEUTICALS INC
Founded2015
MarketPink Market
Securities TypeOrdinary Shares
Fiscal Year Ends08-31
Address601 West Broadway Street,Suite 400
CityVancouver
ProvinceBritish Columbia
CountryCanada
Zip CodeV5Z 4C2
Phone1-604-398-4175

Company Executives

  • Name
  • Position
  • Salary
  • Christopher J. Moreau
  • Chief Executive Officer and Director
  • --
  • James Kinley
  • Chief Financial Officer and Director
  • --
  • Dr. Christopher Bryan
  • Vice President, Research and Operations
  • --
  • Harry J. F. Bloomfield
  • Chairman of the Board
  • --
  • Dr. Ahmad Khalil
  • Medical Director
  • --
  • Howard Gutman
  • Director
  • --
  • Dr. Raj Attariwala
  • Director
  • --
  • Dr. Mark Williams
  • Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg